Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Robert Scott-Millar, Tze‐Fan Chao et al.|EP Europace|2017Cited by 137
The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillationSatoshi Ogawa, Teiichi Yamane, Hung‐Fat Tse et al.|Journal of Arrhythmia|2013Cited by 82